正心谷资本（Loyal Valley Capital）是一家高起点、国际化、充满活力的投资管理公司。正心谷的名字起源于Loyal to our heart，中文则是“正心诚意，虚怀若谷”，这是我们对于投资、商业乃至人生的理解。
Employees: 1-10
Portfolio 40
| Date | Name | Website | Total Raised | Location |
| - | bilibili.c... | bilibili.com | $870M | China |
| - | Immune-Onc | immune-onc.com | $244M | United Sta... |
| - | Sinovent | sinovent.com.cn | $145M | - |
| - | Mahua Fun ... | kaixinmahua.com.cn | - | China, Bei... |
| - | RIGOL TECH... | rigol.com | - | China, Jia... |
| - | NetEase Cl... | music.163.com | $600M | China, Zhe... |
| - | EVE Energy... | evebattery.com | - | China |
| - | SUPCON Tec... | supcon.com | - | - |
| - | 上海和誉生物医药科技... | abbisko.com | $193M | China |
| - | Phyplus | phyplusinc.com | - | - |
Show more
News 6
| Date | Title | Description |
| 02.12.2021 | LVC-backed Cloud Village Lists on the Hong Kong Stock Exchange | On December 2, 2021, Loyal Valley Capital (LVC)’s portfolio company, Cloud Village (referred to as “the Company”), a leading online music streaming platform, successfully listed on the main board of the Hong Kong Stock Exchange under the st... |
| 29.06.2021 | Loyal Valley Capital Charity Fund Unveils Bilingual School In Jiangxi Province | Education charity initiative is part of an ongoing CSR project, backed by Shanghai-based private equity firm Loyal Valley Capital Shanghai, 29 June 2021: Chinese private equity firm Loyal Valley Capital (LVC) and the Bilingual School Affil... |
| 18.06.2021 | LVC-Backed CARsgen Therapeutics Has Successfully Listed on the Hong Kong Stocks Exchange and Made a Breakthrough in Cell Therapy | On June 18th, Loyal Valley Capital (LVC)’s portfolio company CARsgen Therapeutics (2171. HK), a global leader fighting against cancer with CAR-T therapy, was successfully listed on the main board of the Hong Kong Stock Exchange and issued i... |
| 14.12.2020 | Loyal Valley Capital Achieves 11 IPOs In 2020 With Pop Mart Listing In Hong Kong | Leading designer collectibles maker Pop Mart becomes latest fast-growth Chinese company to stage IPO after backing from Shanghai-based private equity firm Loyal Valley Capital Shanghai, 11 Dec 2020: Private equity firm Loyal Valley Capital... |
| 15.07.2020 | LVC-backed Junshi Biosciences makes strong debut on Star Market | Loyal Valley Capital’s portfolio company Junshi Biosciences (688180.SH), the first A/H dual-listed biotech share in China, has made its strong debut on Shanghai’s Sci-Tech innovation board (STAR Market) on July 15, 2020. With a listing pr... |
| 02.12.2019 | Loyal Valley Capital Raises US$465 Million For Its Second USD Fund | Shanghai, China, 2 December, 2019 – Loyal Valley Capital (“LVC”) today announced that Loyal Valley Capital Advantage Fund II LP (“LVC USD Fund II”), held a final close at $465 million in capital commitments, including approximately $25 mill... |
Mentions in press and media 4
| Date | Title | Description |
| 29.04.2026 | Vivacta Bio Closed Series A and Series A+ Financing of Over US$50 Million | Backed by Decheng Capital, Loyal Valley Capital, OrbiMed, and Other Renowned Investors SHANGHAI, April 29, 2026 /PRNewswire/ -- Vivacta Biotechnology (Shanghai) Co., Ltd. ("Vivacta" or "Vivacta Bio"), an innovative biote... |
| 04.12.2019 | Loyal Valley Capital Closes Second USD Fund, at US$465M | Loyal Valley Capital closed its second US dollar-denominated fund, Loyal Valley Capital Advantage Fund II LP, at $465m. The closing include $440m of third-party limited partner commitments and approximately $25m from the general partner. Th... |
| 04.12.2019 | Loyal Valley Capital closes $465 million for its Second Fund to invest in consumer, healthtech and fintech startups in China | Loyal Valley Capital (LVC), a private equity firm that invests in middle market companies in China, announced yesterday that it has closed $465 million for Loyal Valley Capital Advantage Fund II LP (“LVC USD Fund II”). The funding includes ... |
| 02.12.2019 | Loyal Valley Capital Raises US$465 Million For Its Second USD Fund | Shanghai, China, 2 December, 2019 – Loyal Valley Capital (“LVC”) today announced that Loyal Valley Capital Advantage Fund II LP (“LVC USD Fund II”), held a final close at $465 million in capital commitments, including approximately $25 mill... |